Evidence map›Paper›PMID 38059622›Full record

ArticlemBio2024

Epstein-Barr virus induces germinal center light zone chromatin architecture and promotes survival through enhancer looping at the

Joanne Dai, Elliott D SoRelle, Emma Heckenberg, Lingyun Song, Jana M Cable, Gregory E Crawford, Micah A Luftig

Open access · goldAbstract read
In one paragraph

Article in mBio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. A tonsil organoid model reveals Epstein-Barr virus-infected germinal center B cell states during primary infection.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Chromatin Control of EBV Infection and Latency.Current topics in microbiology and immunology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Joanne DaiDepartment of Molecular Genetics and Microbiology, Center for Virology, Duke University School of Medicine, Durham, North Carolina, USA.
Elliott D SoRelleDepartment of Molecular Genetics and Microbiology, Center for Virology, Duke University School of Medicine, Durham, North Carolina, USA.
Emma HeckenbergDepartment of Molecular Genetics and Microbiology, Center for Virology, Duke University School of Medicine, Durham, North Carolina, USA.
Lingyun SongCenter for Genomic & Computational Biology, Duke University, Durham, North Carolina, USA.
Jana M CableDepartment of Molecular Genetics and Microbiology, Center for Virology, Duke University School of Medicine, Durham, North Carolina, USA.
Gregory E CrawfordCenter for Genomic & Computational Biology, Duke University, Durham, North Carolina, USA.
Micah A LuftigDepartment of Molecular Genetics and Microbiology, Center for Virology, Duke University School of Medicine, Durham, North Carolina, USA.ORCID 0000-0002-2964-1907
Duke University · US

Funding

Viral Oncology Training GrantT32CA009111 · NCI · DUKE UNIVERSITY · PI LUFTIG, MICAH A. · 1985 to 2023
$8.9M
Host pathways regulating Epstein-Barr virus-mediated B cell growth transformationR01CA140337 · NCI · DUKE UNIVERSITY · PI LUFTIG, MICAH ALAN · 2011 to 2025
$5.9M
Targeting Apoptosis and Immune Control of Epstein-Barr Virus Infected Tonsillar B CellsR01DE025994 · NIDCR · DUKE UNIVERSITY · PI Micah Alan Luftig · 2016 to 2026
$5.0M
Metabolic regulation of Epstein-Barr Virus-infected tonsillar B cells by EBNA-LPF31DE031509 · NIDCR · DUKE UNIVERSITY · PI CABLE, JANA · 2022 to 2024
$118k
The role of EBNA3A in the survival of Epstein-Barr Virus-infected tonsillar B cellsF31DE027875 · NIDCR · DUKE UNIVERSITY · PI DAI, JOANNE · 2018 to 2019
$72k
NCI NIH HHS R01 CA140337NCI NIH HHS T32 CA009111NIDCR NIH HHS F31 DE027875NIDCR NIH HHS F31 DE031509NIDCR NIH HHS R01 DE025994
6 · The paper itself

Abstract

importanceEpstein-Barr virus has evolved with its human host leading to an intimate relationship where infection of antibody-producing B cells mimics the process by which these cells normally recognize foreign antigens and become activated. Virtually everyone in the world is infected by adulthood and controls this virus pushing it into life-long latency. However, immune-suppressed individuals are at high risk for EBV+ cancers. Here, we isolated B cells from tonsils and compare the underlying molecular genetic differences between these cells and those infected with EBV. We find similar regulatory mechanism for expression of an important cellular protein that enables B cells to survive in lymphoid tissue. These findings link an underlying relationship at the molecular level between EBV-infected B cells in vitro with normally activated B cells

Indexed as

Epstein-Barr Virus InfectionsHerpesvirus 4, HumanProto-Oncogene Proteins c-bcl-2AdultChromatinEpstein-Barr Virus Nuclear AntigensGerminal CenterHumansMinor Histocompatibility AntigensVirus LatencyBCL2-related protein A1ChromatinEpstein-Barr Virus Nuclear AntigensMinor Histocompatibility AntigensProto-Oncogene Proteins c-bcl-2antiapoptosisB-cellchromatinEBVgerminal center

Identifiers

PMID38059622
PMCPMC10790771
OpenAlexW4389435515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.